American Journal of Ophthalmology
Volume 148, Issue 5 , Pages 685-695.e1 , November 2009

Long-term Outcomes of Repeat vs Initial Trabeculectomy in Open-Angle Glaucoma

,Accepted 15 May 2009.

References 

  1. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology. 2007;114:2265–2270
  2. Lichter PR, Musch DC, Gillepsie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953
  3. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994;101:1651–1656discussion 1657
  4. Wilensky JT, Ziemer RC, Gieser DK, Kaplan BH. The effects of glaucoma filtering surgery on the variability of diurnal intraocular pressures. Trans Am Ophthalmol Soc. 1994;92:377–381discussion 381–383
  5. Fontana H, Nouri-Mahdoavi K, Lumba J, Ralli M, Caprioli J. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology. 2006;113:930–936
  6. Fontana H, Nouri-Mahdavi K, Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol. 2006;141:652–659
  7. Grant WM, Burke JF. Why do some people go blind from glaucoma?. Ophthalmology. 1982;89:991–998
  8. Prata Junior JA, Minckler DS, Baerveldt G, Lee PP, LaBree L, Heuer DK. Trabeculectomy in pseudophakic patients: postoperative 5-fluorouracil versus intraoperative mitomycin C antiproliferative therapy. Ophthalmic Surg. 1995;26:73–77
  9. Shingleton BJ, Alfano C, O'Donoghue MW, Rivera J. Efficacy of glaucoma filtration surgery in pseudophakic patients with or without conjunctival scarring. J Cataract Refract Surg. 2004;30:2504–2509
  10. Scott IU, Greenfield DS, Schiffman J, et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol. 1998;116:286–291
  11. Beckers HF, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol. 2003;241:106–110
  12. Casson R, Rahman R, Salmon JF. Long-term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol. 2001;85:686–688
  13. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134:499–512
  14. Musch DC, Gillespie BW, Niziol LM, Cashwell LF, Lichter PRCollaborative Initial Glaucoma Treatment Study Group. Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2008;115:927–933
  15. Rebolleda G, Munoz-Negrete FJ. Effect of cataract surgery on IOP after trabeculectomy [letter]. J Cataract Refract Surg. 2003;29:2043
  16. Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001;10:237–249

PII: S0002-9394(09)00387-0

doi: 10.1016/j.ajo.2009.05.032

American Journal of Ophthalmology
Volume 148, Issue 5 , Pages 685-695.e1 , November 2009

Article Tools

* Image Usage & Resolution